8-KEarnings & ResultsExhibits & Filings

ABBOTT LABORATORIES 8-K Report, Financial Results (Apr 21, 2010)

Filed April 21, 2010For Securities:ABT

Summary

Abbott Laboratories filed an 8-K on April 21, 2010, to report its first-quarter 2010 financial results. The filing primarily serves to furnish a press release detailing these results, which were announced on April 20, 2010. Investors should note that Abbott utilized non-GAAP financial measures in its earnings release, such as net earnings and diluted earnings per share excluding specified items. Management believes these adjusted figures provide a clearer view of ongoing business performance by excluding unusual or unpredictable factors like acquisition costs, currency fluctuations, litigation, and restructuring expenses. While these non-GAAP measures are presented to aid investor understanding, Abbott emphasizes that they should be considered alongside, and not as a replacement for, GAAP-based financial measures.

Key Highlights

  • 1Abbott Laboratories announced its first-quarter 2010 financial results on April 21, 2010, via an 8-K filing.
  • 2The primary purpose of the filing was to furnish a press release containing the Q1 2010 earnings.
  • 3The company reported results of operations and financial condition for the first quarter of 2010.
  • 4Abbott utilized non-GAAP financial measures in its earnings announcement, including net earnings and diluted EPS excluding specified items.
  • 5These non-GAAP measures were presented to offer investors a better evaluation of ongoing business performance.
  • 6Factors adjusted for in the non-GAAP measures include acquisition-related costs, currency devaluations, legislative reforms, litigation settlements, cost reduction initiatives, and product launch costs.
  • 7The company cautioned investors to consider these non-GAAP measures in addition to, not as a substitute for, GAAP financial measures.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report Abbott Laboratories' financial results for the first quarter of 2010 and to furnish the accompanying press release that details these results.

Yes, Abbott Laboratories used non-GAAP financial measures in their Q1 2010 earnings announcement, such as net earnings and diluted earnings per share, excluding certain specified items. These adjustments were made to highlight ongoing business performance by removing unusual or unpredictable factors.

Abbott's management believes that providing non-GAAP financial measures offers valuable insights to investors by allowing them to better evaluate the company's ongoing business performance. These measures adjust for factors that may be unusual or unpredictable, offering a potentially clearer view of operational results.

No, Abbott Laboratories cautions investors to consider these non-GAAP financial measures in addition to, and not as a substitute for, the financial measures prepared in accordance with Generally Accepted Accounting Principles (GAAP). GAAP measures remain the official standard.